Investing in Growth Stocks: WMT, VRTX, PARA, META, and AMZN

In the fiscal third quarter ending on October 31, 2022, WMT’s total revenue saw a year-over-year increase of 8.7%, amounting to $152.81 billion. Its adjusted EPS came in at $1.50, representing a 3.4% year-over-year rise, while its total assets increased by 1.1% from the prior-year value to $247.66 billion.[0] Analysts expect WMT’s revenue to increase 3.9% year-over-year to $145.72 billion for the fiscal first quarter ending April 2023, with an EPS of $1.38, up 6.5% year-over-year.

Vertex Pharmaceuticals (NASDAQ: VRTX) is a stock ripe for the picking. For the past 10 years, the company has grown at an annualized adjusted earnings growth rate of roughly 10%, compared to most electric utilities which are growing by a low single-digit percentage.[1] It expects to develop between 32.7 GW and 41.8 GW of combined wind, solar, energy storage, and wind repowering projects from 2023 through 2026.[1] Vertex also has its sights set on big markets beyond its current Cystic Fibrosis (CF) indications, and could win regulatory approvals as soon as late 2023 for exa-cel in treating sickle cell disease and transfusion-dependent beta-thalassemia.[2]

Another no-brainer stock for investors with $200 ready to invest is Paramount Global (NASDAQ: PARA).[1] This media stock has seen a sizable rebound lately, and is a great buy for those looking for a dependable growth stock with the potential to deliver double-digit returns in the coming decade.[3]

Finally, social media stock Meta Platforms (NASDAQ: META), formerly known as Facebook, is a great buy.[4] With a market cap of only $2 billion and potential to deliver megablockbuster sales, this stock is a no-brainer.

When it comes to growth stocks, one should not underestimate Amazon (AMZN 0.16%). Famous investor Bill Miller recently called Amazon “one of the easiest names in the market right now,” and for good reason.[2] With its long-term prospects looking brighter than ever, the company is on track to launch new products for five disease areas within the next five years, each representing a multibillion-dollar market opportunity.[2]

0. “WMT: 2 No-Brainer Stocks to Buy and Hold Forever”, 15 Feb. 2023,

1. “3 No-Brainer Stocks to Buy With $200 Right Now” msnNOW, 14 Feb. 2023,

2. “The Best Stocks To Invest $5,000 in Right Now” The Motley Fool, 12 Feb. 2023,

3. “Don’t Wait for a Market Bottom: These 2 Stocks Are on Sale” Yahoo Canada Finance, 16 Feb. 2023,

4. “2 “Strong Buy” Stocks Set to Outpace the Market” TipRanks, 15 Feb. 2023,